MARKET NEWS

Verrica Pharmaceuticals Enrolls First Patient in Phase 2 Trial
Y-mAbs Announces Recruitment Status for Pivotal Trials
Therapeutic Solutions International Obtains Exclusive License for Patented Clinical Stage Adult Stem Cell 
Amicus Therapeutics & Brammer Bio Enter Strategic Development & Manufacturing Collaboration
Appili Therapeutics Signs $3-Million Grant  to Develop Antibiotics That Target Superbugs
Calithera Biosciences Initiates Phase 1/2 Trial

  FEATURED EDITORIAL

  COMPANY PROFILE

Evonik is one of the world leaders in specialty chemicals, with more than 36,000 employees across more than 100 countries and €14.4 billion in annual sales in 2017. The Business Line Health Care is a strategic partner to the world’s pharmaceutical companies, we have been helping customers transform their APIs into high-performance medicines for more than 60 years. For oral and parenteral drug delivery, Evonik combines market-leading portfolios of functional excipients with best-in-class formulation development and manufacturing services. Click here for more.

  EXCLUSIVE ONLINE CONTENT

Creating Your Secondary Packaging Strategy - Begin With the End in Mind

Creating Your Secondary Packaging Strategy - Begin With the End in Mind

Whether it is meeting the needs of a rapidly aging market, blocking drug counterfeiters, or differentiating your pharmaceutical product in the market, a secondary packaging program is an important factor in………

Incyte & Zai Lab Announce Collaboration & License Agreement

Incyte & Zai Lab Announce Collaboration & License Agreement

Incyte and Zai Lab Ltd. recently announced that the companies have entered into a collaboration and license agreement for the development and commercialization of

Amicus Therapeutics & Catalent Biologics Enter Strategic Partnership 

Amicus Therapeutics & Catalent Biologics Enter Strategic Partnership 

Amicus Therapeutics, Inc. has entered into a strategic manufacturing agreement with Paragon Gene Therapy, a unit of Catalent Biologics, for clinical manufacturing capabilities and capacity for….

Designing a CMC Strategy for Accelerated Development of Biotherapeutics

Designing a CMC Strategy for Accelerated Development of Biotherapeutics

As the pipeline of biologic drugs intended to treat complex disease expands, the typical timeline for drug development seems to be shortening more frequently and with more intensity……..

  DRUG DEVELOPMENT DIRECT RESOURCES

Upcoming eNewsletter Features:

August 7 – Controlled Release
August 14 – Analytical Testing